Environmental Factors as Determinants of Severity of SCD in Nigeria
Journal Title: Haematology International Journal - Year 2018, Vol 2, Issue 4
Abstract
Sickle cell anaemia (SCA) is a chronic blood disorder characterized by red blood cells that assume an abnormal sickle shape when deoxygenated and may block different areas of the microcirculation causing ischaemia in various organs. This study was carried out to find out the roles of environmental factors in determining the clinical severity of SCA in Nigeria. 1.1. Subjects and Methods: This was a multicentre cross-sectional study amongst 261 SCA subjects in seven tertiary health care centres in Nigeria. After obtaining each Institution’s ethics and research committee approval, a pretested structured questionnaire was administered to respondents by trained research assistants. Subjects were asked questions on number of crises, number of transfusions and number of hospitalizations in the previous one year 1.2. Results: Jos Centre had the highest frequency (30%) of those who had more than three crises in the previous one year while Calabar (9.3%) and Lagos (10%) had the least. Frequency of more than three transfusions was highest in Maiduguri (6.3%) and Abuja(6.3%) respectively with Lagos, Enugu and Calabar centres in the southern part of Nigeria recording no transfusion during the study period. Calabar centre had the highest number of people (90.6%) who had not been transfused before and those who had not been hospitalized (71.9%). Maiduguri (16.7%) and Jos (15%) topped the number of those who had been hospitalized for more than three times while Lagos (0%) and Calabar (3.1) had the least. 1.3. Conclusion: Altitude and hot weather are major environmental factors that contribute to the clinical severity of SCD in Nigeria.
Authors and Affiliations
Tamunomieibi Wakama
Keywords
Related Articles
- EP ID EP404335
- DOI 10.23880/hij-16000132
- Views 113
- Downloads 0
Transfusion Support and Red Cell Alloimmunisation in Thalassemia Patients
Thalassemias are the most common mono genetic disease worldwide. It has high frequency extending from the Mediterranean basin through the Middle East (Iran), India and Southeast Asia. In India, the carrier rate of Beta T...
Expanding the Classification of Leukemia by the World Health Organization over Time
The classification has always been the basis for many treatments of the disease. The French-American-British has performed leukemia classification base on morphological finding, but the World Health Organization apply ge...
Cladribine an Alternative for Midostaurine in FLT3 Positive Acute Myeloid Leukemia
Midostaurinis registered for the indication newly diagnosed acute myeloid leukemia that is FLT3 mutation positive in combination with standard cytarabine and daunorubicine induction and cytarabine consolidation. The regi...
The Stellar, Astral Reproduction: Burkitt ‘S Lymphoma
An infrequent (≤1.2%), aggressive B lymphocyte non hodgkin’s lymphoma is designated as a Burkitt’s lymphoma, which may present as an extra-nodal tumefaction or as an acute leukaemia [1]. A well delineated clinico-patholo...
Role of α-1 Anti Trypsin, A Constitutive Form of Nitric Oxide Synthase in Cyclic AMP Mediated Inhibition of Platelet Aggregation
1.1. Introduction: As reported before, the treatment of platelets with all currently known platelet aggregating agents was resulted in the reduction of nitric oxide (NO) synthesis through the inhibition of enzyme nitric...